BELLEVUE, WA – Novo Integrated Sciences, Inc. (NASDAQ:NVOS), a diversified healthcare ecosystem company, announced the appointment of Mr. Robert Oliva as its new President.
Mr. Oliva has over 35 years of experience in business development and manufacturing operations. He succeeds Mr. Christopher David, who will continue to serve as Chief Operating Officer and retain his seat on the Board of Directors.
The company’s CEO and Chairman Robert Mattaccione commented: “Mr. Oliva’s arrival comes at a time when the Company is dedicating significant efforts and resources to expanding its production and product offerings. His years of building a manufacturing business from scratch to a meaningful and profitable enterprise will be a tremendous asset in providing oversight and guidance to the company’s leadership team.”
Novo Integrated Sciences is known for its holistic approach to healthcare, integrating medical technology, advanced treatments and rehabilitation science to provide patient-centered health and wellness services.
The company’s approach to decentralizing health care aims to move unsustainable care from primary care centers to patients’ homes, leveraging advances in medical technology and connectivity. This model is designed to prevent exacerbation of non-critical health conditions and ensure a more cost-effective distribution of health care services.
The information in this article is based on a press statement from Novo Integrated Sciences.
This article was created with the help of AI and reviewed by an editor. For more information please see our Terms and Conditions.